Information Provided By:
Fly News Breaks for February 24, 2020
Feb 24, 2020 | 08:46 EDT
Sidoti analyst Anthony Lebiedzinski downgraded PetMed Express (PETS) to Neutral from Buy with an unchanged price target of $31. The shares have rallied 90% since reaching a 52-week low of $15 on July 12, leaving limited upside potential, noted Lebiedzinski. The analyst also noted that competition will remain "fierce," especially from (CHWY).
News For PETS;CHWY From the Last 2 Days
There are no results for your query PETS;CHWY